Medicine at Michigan
Medicine at Michigan
Medicine at Michigan About Current Issue Past Issues Contact Development and Alumni Relations
   
Spacer
Fall 2003
Departments
Dean's Letter
Letters
Above the Huron
Moments
Class Notes
CME
Limelight
Greenfield's Message
 
Credits
 
Ways to Give
   Magazine
   Keyword
  
                

 

 

Why Some People Get Sick... and Others Get Sicker

A gene that turns a chronic inherited neurological disorder — which produces tremor and muscle weakness in laboratory mice — into a lethal disease that paralyzes and kills them within a few weeks of birth, has been discovered by U-M scientists. Called Scnm1, the gene is one of a small group of recently discovered "modifier" genes that interact with other genes to alter the physical effects of inherited diseases.


Michelle Trudeau, Miriam Meisler and David Buchner
Photo: Marcia Ledford

There are many inherited diseases — including cystic fibrosis, amyotrophic lateral sclerosis (ALS) and epilepsy — where symptoms vary widely, even between members of the same family. Understanding how modifier genes work could help scientists solve a fundamental mystery of genetics: Why do people with identical genetic mutations often differ in the severity or age of onset of the same inherited disease?

"In our study with mice, we found that the severity of neurological defects caused by mutations in a gene called Scn8a are determined by another gene, Scnm1, which is located on a different chromosome," says Miriam Meisler, Ph.D., a professor of human genetics in the U-M Medical School. "Scnm1 is expressed in many human cells, which suggests that it could modify the severity of a wide range of inherited disorders in humans, including other neurological diseases."

Meisler's research focuses on sodium channel genes that control the flow of electrical signals between nerve and muscle cells. Mutations in sodium channel genes produce a variety of neurological disorders — including several types of epilepsy, ataxia, poor muscle coordination, paralysis and cardiac arrhythmias like long QT syndrome.

"If we can find a way to change the secondary effects of modifier genes, we may be able to minimize the impact of the original genetic defect," Meisler says.

The U-M study was funded by the National Institutes of Health. Meisler conducted the study with David Buchner, a U-M graduate student, and Michelle Trudeau, a U-M research associate.

-SFP

 

Read an expanded version:
www.med.umich.edu/opm/newspage/2003/scnm1.htm

More information on modifier genes:
www.med.umich.edu/genetics/faculty/meislermore.htm

 

PreviousNext

 

 

Features
Support
Scholarship Support
Spacer

 

Download PDF

 

 

 

Copyright 2003 University of Michigan Medical School

 

Spacer